Dubai [UAE], April 12 (ANI): Habil Khorakiwala, Chairman of Indian pharmaceutical company Wockhardt, on Friday said 'Zaynich,' its medicine for multi-drug resistant infections, is set to get the US ...

Mumbai (Maharashtra) [India], September 27: Wockhardt under the leadership of Dr Khorakiwala has become the world leader in anti-bacterial research, with 6 of its products having QIDP for the industry ...

MUMBAI (Reuters) - Drugmaker Wockhardt's steps to have the United States lift bans on products from two of its plants are unlikely to approved until next year, its chairman said on Monday after the ...

“In your darkest hour you have two options: One, you get overwhelmed by the massive extent of the problem and it paralyses you from any action the other, you anticipate the worst case scenario and ...

Wockhardt’s Habil Khorakiwala has unveiled his autobiography – Odyssey of Courage. The book recounts four different transformation journeys from the time he started his company and survived in the ...

Wockhardt Ltd that built its name as a maker of generic drugs is shifting its focus in the US market to developing new antibiotics, turning away from generics and entering a space largely vacated by ...

In the summer of 2013, Wockhardt Chairman Habil Khorakiwala had finally begun to breathe easy after five years of losses, asset sales, court cases and corporate-debt restructuring. During an ...

MUMBAI (Reuters) - Shares in Wockhardt Ltd(WCKH.NS) fell as much as 5.3 percent on Thursday after the drugmaker said the U.S. Food and Drug Administration had raised fresh concerns about a plant ...

Habil Khorakiwala, the Chairman of Wockhardt Ltd., said he expects US approval for the novel antibiotic Zaynich by mid-2026. “The review process may take six to eight months. We are very confident of ...

In July, the Mumbai-based firm had received a warning letter from US Food and Drug Administration (USFDA) over its facility at Waluj in Maharashtra for not meeting manufacturing norms. Advisory Alert: ...

WOCKHARDT UNDER THE LEADERSHIP OF DR KHORAKIWALA HAS BECOME THE WORLD LEADER IN ANTI-BACTERIAL RESEARCH: with 6ofitsproductshavingQIDPfor the industry. MUMBAI, India, Sept. 27, 2024 /PRNewswire/ -- ...